Omega-3 MaxPower 60cap - Vegafarma

Omega-3 MaxPower 60cap - Vegafarma

Omega 3 MaxPower contains EPA 700mg and DHA 500mg per daily dose.

The three main omega-3 fatty acids are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). These are important for several bodily functions, including muscle activity, blood clotting, digestion, fertility, and cell division and growth. DHA is important for brain development and function, and ALA is an essential fatty acid.

Omega-3 MaxPower 60cap - Vegafarma

Omega-3 MaxPower contains EPA 700mg and DHA 500mg per daily dose.

The three main omega-3 fatty acids are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). These are important for several bodily functions, including muscle activity, blood clotting, digestion, fertility, and cell division and growth. DHA is important for brain development and function, and ALA is an essential fatty acid.

Fish oil supplementation provides several benefits, particularly when the body's ω3:ω6 ratio is nearly balanced. The Western diet is overly rich in ω6 (red meat, eggs, soybeans, sunflower and palm oils, among others). ω3 is recommended to balance this ratio (the human body cannot produce ω3). A 1:1 ratio of ω3:ω6 is associated with a reduced risk of arterial and lipid health, as well as a lower risk of atheromatous plaque accumulation. It may also reduce the risk of diabetes (and other metabolic syndromes) and various forms of cancer (including breast cancer).

EPA is a polyunsaturated fatty acid (PUFA) that acts as a precursor to several eicosanoids such as prostaglandin E3 (PGE3 – which inhibits platelet aggregation), thromboxanes A3 (TXA3), and leukotriene B5 (LTB5). DHA is an omega-3 polyunsaturated fatty acid that is a primary structural component of the human brain, cerebral cortex, and retina. It is very important in brain and retinal phospholipids and has been suggested as relevant in the prevention and treatment of Alzheimer's disease. DHA is the most abundant omega-3 fatty acid in the brain and retina, comprising approximately 40% of brain PUFAs and 60% of retinal PUFAs. It is reported that 50% of the neuronal membrane weight is composed of DHA. The control of apoptosis is dependent on phosphatidylserine (PS) and low levels of DHA decrease neuronal cellular PS and increase cell death, which means that DHA deficiency is associated with cognitive decline.

Main indications: Hypertriglycerinemia, cardiovascular disease and hypertension, prevention of obstruction after angioplasty, non-alcoholic steatohepatitis, hepatic steatosis, non-alcoholic fatty liver disease (NAFLD).

Other indications: In the adjuvant treatment of endometriosis, arterial hypertension or kidney damage caused by cyclosporines, dyspraxia, dysmenorrhea and PMS, heart failure and coronary transplantation, hypercholesterolemia caused by HIV/AIDS or after kidney transplantation, IgA nephropathy, osteoporosis, psoriasis, rheumatoid arthritis.

Health claims: DHA contributes to the maintenance of normal brain function; DHA contributes to the maintenance of normal vision; EPA and DHA contribute to normal heart function. This beneficial effect is achieved with a daily dose of 250 mg of EPA and DHA; Vitamin E contributes to the protection of cells against undesirable oxidation.

Packaging contains 60 capsules